Genus (GNS) Receives Buy Rating from Peel Hunt

Share on StockTwits

Peel Hunt reaffirmed their buy rating on shares of Genus (LON:GNS) in a research note published on Monday.

Several other equities analysts have also commented on the company. HSBC reaffirmed a buy rating and issued a GBX 2,700 ($35.28) price target (up previously from GBX 2,650 ($34.63)) on shares of Genus in a research note on Monday, March 11th. Liberum Capital raised Genus to a buy rating and upped their price target for the company from GBX 2,400 ($31.36) to GBX 2,500 ($32.67) in a research note on Tuesday, March 5th. Finally, Kepler Capital Markets raised Genus to a buy rating and upped their price target for the company from GBX 2,475 ($32.34) to GBX 2,630 ($34.37) in a research note on Thursday, December 6th.

LON GNS opened at GBX 2,226 ($29.09) on Monday. The firm has a market cap of $1.44 billion and a price-to-earnings ratio of -206.11. The company has a current ratio of 2.08, a quick ratio of 1.32 and a debt-to-equity ratio of 22.58. Genus has a fifty-two week low of GBX 2,090 ($27.31) and a fifty-two week high of GBX 2,998 ($39.17).

The firm also recently declared a dividend, which will be paid on Thursday, April 4th. Stockholders of record on Thursday, March 7th will be paid a GBX 8.90 ($0.12) dividend. This represents a dividend yield of 0.41%. The ex-dividend date of this dividend is Thursday, March 7th. Genus’s dividend payout ratio (DPR) is presently -2.50%.

Genus Company Profile

Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand.

Featured Article: What are the benefits of a balanced fund?

Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

BioScrip  Hits New 1-Year Low at $1.68
BioScrip Hits New 1-Year Low at $1.68
Novacoin Price Hits $0.53 on Top Exchanges
Novacoin Price Hits $0.53 on Top Exchanges
Niobio Cash Hits 1-Day Volume of $427.00
Niobio Cash Hits 1-Day Volume of $427.00
BitMart Token  Price Hits $0.0265 on Top Exchanges
BitMart Token Price Hits $0.0265 on Top Exchanges
Contrasting X Financial  and Its Peers
Contrasting X Financial and Its Peers
Zacks: Brokerages Anticipate Aphria Inc  Will Post Quarterly Sales of $81.65 Million
Zacks: Brokerages Anticipate Aphria Inc Will Post Quarterly Sales of $81.65 Million


© 2006-2019 Ticker Report